Due to the age of the patients and the degenerative nature of LCA, the improvement of vision in gene therapy patients is encouraging for researchers.
Debido á idade dos pacientes e a natureza dexenerativa da ACL, a mellora da vista nos pacientes de terapia xénica anima os investigadores.